abstract |
This use of cyclooxygenase-2 inhibitors in the manufacture of a medicament for preventing and treating neoplasia. The use particularly relates to medicaments that treat or prevent epithelial cell neoplasia comprising a compound of Formula (II) wherein R4 is lower haloalkyl; wherein R5 is hydrido; and wherein R6 is phenyl optionally substituted at a substitutable position with one or more radicals selected from halo, lower alkylthio, lower alkylsulfonyl, cyano, nitro, lower haloalkyl, lower alkyl, hydroxyl, lower alkenyl, lower hydroxyalkyl, carboxyl, lower cycloalkyl, lower alkylamino, lower dialkylamino, lower alkoxycarbonyl, aminocarbonyl, lower alkoxy, lower haloalkoxy, sulfamyl, five or six membered heterocyclic and amino; or a pharmaceutically-acceptable salt or derivative thereof. |